Your Best Stock

GlaxoSmithKline GSK

$49.77
+$0.06 (+0.11%)
Market open · Sep 24, 1:10 pm ET
After hours $49.71 0.00%
Open$49.54
Prev close$49.71
Day range$49.57 – $50.14
Volume1.43M
Market cap$99.70B
P/E (TTM)16.0
Dividend yield3.56%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026 · reported in GBP

Revenue£8.41B+5.3% YoY
Operating profit£481.00M-76.2% YoY
Net profit£553.00M-66.4% YoY
Diluted EPS£0.21-69.5% YoY
Free cash flow£2.04B+39.2% YoY
Operating cash flow£2.69B

Revenue, last 8 quarters

£8.0BSep '24£8.1BDec '24£7.5BMar '25£8.0BJun '25£8.5BSep '25£8.6BDec '25£7.6BMar '26£8.4BJun '26

Net profit, last 8 quarters

£65.0MSep '24£501.0MDec '24£1.8BMar '25£1.6BJun '25£2.1BSep '25£727.0MDec '25£1.8BMar '26£553.0MJun '26

Diluted EPS by quarter

-0.03Sep '240.20Dec '240.79Mar '250.70Jun '250.98Sep '250.31Dec '250.85Mar '260.21Jun '26

Free cash flow by quarter

£1.3BSep '24£1.2BDec '24£697.0MMar '25£1.5BJun '25£1.3BSep '25£1.3BDec '25£698.0MMar '26£2.0BJun '26

Annual revenue

£24.4BFY20£24.7BFY21£29.3BFY22£30.3BFY23£31.4BFY24£32.7BFY25

Profitability & balance sheet

Gross margin72.7%
Operating margin20.7%
Net margin14.5%
Return on equity29.7%
Return on assets8.0%
Return on invested capital15.9%
Current ratio0.82
Liabilities / assets72.2%
Cash & investments£3.11B
Total debt£13.95B
Net cash (debt)-£10.84B
Free cash flow / sales16.1%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q2
(GBP)
2026 Q1
(GBP)
2025 ANNUAL
(GBP)
2025 Q4
(GBP)
2025 Q3
(GBP)
Total Revenue as Reported £8.41B £7.63B £32.67B £8.62B £8.55B
Total Operating Revenue £8.41B £7.63B £32.67B £8.62B £8.55B
Cost of Revenue £2.27B £1.88B £9.02B £2.66B £2.26B
Gross Profit £6.14B £5.75B £23.65B £5.96B £6.29B
Operating Expense £5.66B £3.46B £15.31B £4.46B £3.70B
Selling and Admin Expenses £2.20B £2.12B £9.09B £2.64B £2.24B
-General & Admin Expense £2.20B £2.12B £9.09B £2.64B £2.24B
Research & Development £3.47B £1.69B £7.53B £2.35B £1.69B
Other Operating Expenses £198.00M
Operating Profit £481.00M £2.29B £8.34B £1.51B £2.59B
Net Non-Operating Interest Income (Expense) -£124.00M -£145.00M -£633.00M -£250.00M -£141.00M
Non-Operating Interest Income £58.00M £22.00M £56.00M -£74.00M £26.00M
Non-Operating Interest Expense £182.00M £167.00M £687.00M £174.00M £167.00M
Pretax Profit £354.00M £2.14B £7.40B £950.00M £2.46B
Tax -£199.00M £305.00M £1.11B £223.00M £312.00M
Net Profit £553.00M £1.84B £6.29B £727.00M £2.14B
Profit from Continuing Operations £553.00M £1.84B £6.29B £727.00M £2.14B
Minority Interests £118.00M £102.00M £573.00M £91.00M £131.00M
Net Income to Parent Company £435.00M £1.74B £5.72B £636.00M £2.01B
Other Preferred Stock Dividends £0.00 £0.00 £0.00 £0.00 £0.00
Net Income to Common Stockholders £435.00M £1.74B £5.72B £636.00M £2.01B
Basic EPS £0.22 £0.86 £2.82 £0.32 £1.00
Diluted EPS £0.21 £0.85 £2.78 £0.31 £0.98
Dividend Per Share £0.34 £0.35 £1.29 £0.33 £0.32
Total Other Finance Costs £2.00M
Special Income (Charges) -£813.00M
-Less:Restructuring and Mergern & Acquisition £581.00M
-Less:Other Special Charges £232.00M

Balance sheet

Line item 2026 Q2
(GBP)
2026 Q1
(GBP)
2025 ANNUAL
(GBP)
2025 Q4
(GBP)
2025 Q3
(GBP)
Total Assets £61.74B £62.87B £61.12B £61.12B £61.34B
Total Current Assets £17.56B £17.76B £17.51B £17.51B £17.84B
Cash and Cash Equivalents & Short-Term Investments £3.11B £3.44B £3.16B £3.16B £3.31B
-Cash and Cash Equivalents £3.11B £3.44B £3.15B £3.15B £3.30B
-Short Term Investments £1.00M £1.00M £9.00M £9.00M £10.00M
-Accounts Receivable £7.71B £7.76B £5.91B £5.91B £7.94B
-Taxes Receivable £368.00M £181.00M £799.00M £799.00M £367.00M
Inventory £6.28B £6.16B £5.92B £5.92B £6.12B
Total Non-Current Assets £44.18B £45.11B £43.61B £43.61B £43.50B
Net PPE £10.03B £10.04B £10.05B £10.05B £10.13B
-Gross PPE £10.03B £10.04B £20.94B £20.94B £10.13B
-Long Term Equity Investment £101.00M £99.00M £89.00M £89.00M £129.00M
Financial Assets £17.00M £19.00M £0.00 £0.00 £0.00
Goodwill and Other Intangible Assets £24.18B £25.43B £23.77B £23.77B £23.98B
-Goodwill £7.38B £7.29B £7.02B £7.02B £7.12B
-Other Intangible Assets £16.80B £18.14B £16.75B £16.75B £16.87B
Other Non-Current Assets £2.65B £2.36B £2.13B
Total Liabilities £44.56B £45.45B £45.16B £45.16B £45.59B
Total Current Liabilities £21.53B £22.43B £21.39B £21.39B £21.33B
Payables £14.87B £14.89B £4.47B £4.47B £16.00B
-Accounts Payable £14.34B £14.34B £3.54B £3.54B £15.68B
-Total Tax Payable £524.00M £555.00M £498.00M £498.00M £324.00M
Short-Term Debt and Capital Lease Obligation £4.29B £5.04B £3.01B £3.01B £2.86B
Current Provisions £844.00M £908.00M £938.00M £938.00M £1.13B
Other Current Liabilities £1.38B £1.40B £1.35B £1.35B £1.24B
Total Non-Current Liabilities £23.03B £23.02B £23.77B £23.77B £24.25B
Long Term Debt and Capital Lease Obligation £13.95B £14.01B £14.71B £14.71B £14.89B
Derivative Product Liabilities £55.00M £56.00M £67.00M £67.00M £66.00M
Non-Current Liabilities £610.00M £579.00M £610.00M £610.00M £673.00M
Other Non-Current Liabilities £6.49B £6.32B £5.39B £5.39B £6.57B
Total Equity £17.18B £17.42B £15.96B £15.96B £15.75B
Stockholders' Equity £17.65B £17.85B £16.38B £16.38B £16.15B
Capital Stock £1.35B £1.35B £1.35B £1.35B £1.35B
-Common Stock £1.35B £1.35B £1.35B £1.35B £1.35B
Additional Paid-In Capital £3.51B £3.51B £3.50B £3.50B £3.49B
Retained Earnings £11.46B £11.59B £10.21B £10.21B £10.02B
Minority Interests -£468.00M -£430.00M -£421.00M -£421.00M -£396.00M
Long Term Accounts Payable and Other Payables £66.00M £896.00M £896.00M
-Other Receivables £662.00M £662.00M
Prepaid Assets £385.00M £385.00M
Restricted Cash £247.00M £247.00M
-Accumulated Depreciation -£10.89B -£10.89B
-Available for Sale Securities £790.00M £790.00M
Defined Pension Benefit £1.12B £1.12B
-Other Payable £438.00M £438.00M
-Current Debt £2.88B £2.88B
-Current Capital Lease Obligation £137.00M £137.00M
Non-Current Accrued Expenses £6.00M £6.00M
-Long Term Debt £14.02B £14.02B
-Long Term Capital Lease Obligation £693.00M £693.00M
Other Equity Interests -£282.00M -£282.00M

Cash flow

Line item 2026 Q2
(GBP)
2026 Q1
(GBP)
2025 ANNUAL
(GBP)
2025 Q4
(GBP)
2025 Q3
(GBP)
Operating Cash Flow £2.69B £1.14B £7.74B £2.28B £2.22B
Net Income from Continuing Operations £553.00M £1.84B £6.29B £727.00M £2.14B
Deferred Tax -£199.00M £305.00M £1.11B £223.00M £312.00M
Other Non-Cash Items £124.00M £145.00M £568.00M £185.00M £141.00M
Change in Working Capital £560.00M -£1.08B -£1.44B £588.00M -£206.00M
Net cash flow from investing -£789.00M -£1.47B -£4.23B -£933.00M -£1.53B
Net PPE Purchase and Sale -£325.00M -£194.00M -£1.32B -£560.00M -£306.00M
Net Intangibles Purchase and Sale -£32.00M -£160.00M -£1.52B -£449.00M -£532.00M
Net Business Purchase and Sale -£526.00M -£1.17B -£1.64B -£31.00M -£746.00M
Net Investment Purchase and Sale £0.00 £9.00M £11.00M £0.00 £11.00M
Financing Cash Flow -£2.15B £272.00M -£3.69B -£856.00M -£1.32B
Net Issuance Payments Of Debt -£632.00M £1.18B £1.51B £548.00M -£86.00M
Net Common Stock Issuance -£307.00M -£318.00M -£1.36B -£251.00M -£317.00M
Cash Dividends Paid -£727.00M -£643.00M -£2.56B -£646.00M -£650.00M
Net Other Financing Charges -£35.00M £1.70B £46.00M -£25.00M -£48.00M
Ending Cash Balance £2.94B £3.20B £3.21B £3.21B £2.76B
Net Change in Cash -£248.00M -£53.00M -£177.00M £489.00M -£624.00M
Beginning Cash Balance £3.20B £3.25B £3.40B £2.76B £3.32B
Effect of Exchange Rate Changes -£7.00M £2.00M -£19.00M -£41.00M £59.00M
Free Cash Flow £2.04B £698.00M £4.76B £1.25B £1.34B
-Change in Receivables -£1.10B
-Change in Inventory -£140.00M
-Change in Other Current Assets -£1.14B
-Change in Other Current Liabilities £465.00M
Scroll to Top